Alkosign Technologies Limited has submitted a regulatory disclosure to the BSE SME Platform regarding an upcoming board meeting. The meeting of the Board of Directors is scheduled to be held on Friday, 13th November, 2026.
The primary agenda items for the board meeting include:
- Consideration and approval of the Standalone and Consolidated Unaudited financial results for the half year ended September 30, 2026
- Consideration and approval of the Limited Review report for the same period
- Any other matter with the permission of the chair
The company also provided an update regarding its insider trading compliance measures. In continuation of their previous intimation dated September 29, 2026, the Trading Window for dealing in the equity shares of the Company has been closed since October 01, 2026, in accordance with the Company's Code of Conduct for prevention of Insider Trading framed under the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.
The Trading Window will remain closed until 48 hours after the communication of the financial results to the Stock Exchange. The disclosure is made pursuant to Regulation 29 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.